Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Hamilton-Dutoit

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|February 18, 2011
CYP2D6 inhibition and breast cancer recurrence in a population-based study in DenmarkTimothy L Lash, Deirdre Cronin-Fenton, Thomas P Ahern, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|September 3, 2021
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorderTrine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.
Annals of Medicine and Surgery (2012)|November 14, 2015
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverLin Nanna Okholm Møller, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, et al.
Journal of Hepatology|July 8, 2018
Urea cycle dysregulation in non-alcoholic fatty liver diseaseFrancesco De Chiara, Sara Heebøll, Giusi Marrone, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|February 18, 2011
CYP2D6 inhibition and breast cancer recurrence in a population-based study in DenmarkTimothy L Lash, Deirdre Cronin-Fenton, Thomas P Ahern, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|September 3, 2021
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorderTrine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.
Annals of Medicine and Surgery (2012)|November 14, 2015
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverLin Nanna Okholm Møller, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, et al.
Journal of Hepatology|July 8, 2018
Urea cycle dysregulation in non-alcoholic fatty liver diseaseFrancesco De Chiara, Sara Heebøll, Giusi Marrone, et al.
Pageof 13